LEADER 01414nam  2200397Ia 450 
001 9910696955703321
005 20230902162032.0
035   $a(CKB)5470000002383334
035   $a(OCoLC)549153718
035   $a(EXLCZ)995470000002383334
100   $a20100309d1997      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry$b[electronic resource] $eaerosol steroid product safety information in prescription drug advertising and promotional labeling
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research,$d[1997]
215   $a1 online resource (3 unnumbered pages)
300   $a"DDMAC 1."
300   $a"December 1997."
517   $aGuidance for industry 
606   $aSteroid drugs$xLabeling$zUnited States
606   $aAerosol therapy$zUnited States
606   $aAdvertising$xDrugs$zUnited States
615  0$aSteroid drugs$xLabeling
615  0$aAerosol therapy
615  0$aAdvertising$xDrugs
712 02$aCenter for Drug Evaluation and Research (U.S.)
712 02$aCenter for Biologics Evaluation and Research (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910696955703321
996   $aGuidance for industry$93434577
997   $aUNINA